Lack of evidence for an unmet need to treat clostridium difficile infection in infants aged <2 years: Expert recommendations on how to address this issue

Clinical Infectious Diseases

Volumn 60, Issue 6, 2015, Pages 912-918

  Faust, Saul N ^a   Wilcox, Mark H ^b   Banaszkiewicz, Aleksandra ^c   Bouza, Emilio ^d   Raymond, Josette ^e   Gerding, Dale N ^f  

^a UNIVERSITY HOSPITAL SOUTHAMPTON NHS FOUNDATION TRUST   (United Kingdom)

^b UNIVERSITY OF LEEDS   (United Kingdom)

^c MEDICAL UNIVERSITY OF WARSAW   (Poland)

^d UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

^e UNIVERSITÉ PARIS DESCARTES   (France)

^f LOYOLA UNIVERSITY CHICAGO   (United States)

Author keywords

C. difficile infection; Clinical trial; Diarrhea; Infants; Pediatrics

Indexed keywords

ARTICLE; CLINICAL TRIAL (TOPIC); CLOSTRIDIUM DIFFICILE INFECTION; DIARRHEA; DISEASE CONTROL; DISEASE COURSE; DRUG INDUSTRY; DRUG SAFETY; HUMAN; INFANT; INFANT DISEASE; INTERVENTION STUDY; NONHUMAN; OUTCOME ASSESSMENT; PEPTOCLOSTRIDIUM DIFFICILE; PRIORITY JOURNAL; PROPHYLAXIS; CLOSTRIDIUM INFECTIONS; FEMALE; MALE;

ANTIINFECTIVE AGENT;

ANTI-BACTERIAL AGENTS; CLINICAL TRIALS AS TOPIC; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM INFECTIONS; FEMALE; HUMANS; INFANT; MALE;

EID: 84929851070     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/ciu936     Document Type: Article

References (32)

1. Khanna S, Pardi DS. Clostridium difficile infection: new insights into management. Mayo Clin Proc 2012; 87:1106-17.
2. Cerquetti M, Luzzi I, Caprioli A, Sebastianelli A, Mastrantonio P. Role of Clostridium difficile in childhood diarrhea. Pediatr Infect Dis J 1995; 14:598-603.
3. Jangi S, Lamont JT. Asymptomatic colonization by Clostridium difficile in infants: implications for disease in later life. J Pediatr Gastroenterol Nutr 2010; 51:2-7.
4. The European Parliament and the Council of the European Union. Regulation (EC) No 1901/2006 of the European Parliament and of the Council of 12 December 2006: on medicinal products for paediatric use. Official J Eur Union 2006; 27:L 378-1-L 378/19.
5. Senate and House of Representatives of the United States of America. Food and Drug Administration Amendments Act of 2007. Available at: http://www.fda.gov/regulatoryinformation/legislation/federalfood drugandcosmeticactfdcact/significantamendmentstothefdcact/foodand drugadministrationamendmentsactof2007/default.htm. Accessed 22 April 2014.
6. Viscidi R,Willey S, Bartlett JG. Isolation rates and toxigenic potential of Clostridium difficile isolates from various patient populations. Gastroenterology 1981; 81:5-9.
7. Rousseau C, Poilane I, De Pontual L, Maherault AC, Le Monnier A, Collignon A. Clostridium difficile carriage in healthy infants in the community: A potential reservoir for pathogenic strains. Clin Infect Dis 2012; 55:1209-15.
8. Stoesser NE, Martin J, Mawer D, et al. Risk factors for Clostridium difficile acquisition in infants: importance of study design. Clin Infect Dis 2013; 56:1680-1.
9. Denno DM, Shaikh N, Stapp JR, et al. Diarrhea etiology in a pediatric emergency department: A case control study. Clin Infect Dis 2012; 55:897-904.
10. Bryant K, McDonald LC. Clostridium difficile infections in children. Pediatr Infect Dis J 2009; 28:145-6.
11. Kim J, Smathers SA, Prasad P, Leckerman KH, Coffin S, Zaoutis T. Epidemiological features of Clostridium difficile-associated disease among inpatients at children's hospitals in the United States, 2001-2006. Pediatrics 2008; 122:1266-70.
12. Nylund CM, Goudie A, Garza JM, Fairbrother G, Cohen MB. Clostridium difficile infection in hospitalized children in the United States. Arch Pediatr Adolesc Med 2011; 165:451-7.
13. Zilberberg MD, Tillotson GS, McDonald C. Clostridium difficile infections among hospitalized children, United States, 1997-2006. Emerg Infect Dis 2010; 16:604-9.
14. Tang P, Roscoe M, Richardson SE. Limited clinical utility of Clostridium difficile toxin testing in infants in a pediatric hospital. Diagn Microbiol Infect Dis 2005; 52:91-4.
15. National Collaborating Centre for Women's and Children's Health. Diarrhoea and vomiting caused by gastroenteritis: diagnosis, assessment and management in children younger than 5 years. Available at: http:// www.nice.org.uk/guidance/cg84/evidence/cg84-diarrhoea-and-vomitingin-children-under-5-full-guideline2. Accessed 22 April 2014.
16. Wendt JM, Cohen JA, Mu Y, et al. Clostridium difficile infection among children across diverse US geographic locations. Pediatrics 2014; 133:651-8.
17. Planche TD, Davies KA, Coen PG, et al. Differences in outcome according to Clostridium difficile testing method: A prospective multicentre diagnostic validation study of C. difficile infection. Lancet Infect Dis 2013; 13:936-45.
18. Eglow R, Pothoulakis C, Itzkowitz S, et al. Diminished Clostridium difficile toxin A sensitivity in newborn rabbit ileum is associated with decreased toxin A receptor. J Clin Invest 1992; 90:822-9.
19. Morinville V, McDonald J. Clostridium difficile-associated diarrhea in 200 Canadian children. Can J Gastroenterol 2005; 19:497-501.
20. Khanna S, Baddour LM, Huskins WC, et al. The epidemiology of Clostridium difficile infection in children: A population-based study. Clin Infect Dis 2013; 56:1401-6.
21. Quesada-Gómez C, Vargas P, López-Ureña D, Gamboa-Coronado MM, Rodríguez-Cavallini E. Community-acquired Clostridium difficile NAP1/027-associated diarrhea in an eighteen month old child. Anaerobe 2012; 18:581-3.
22. Huang SC, Yang YJ, Lee CT. Rectal prolapse in a child: an unusual presentation of Clostridium difficile-associated pseudomembranous colitis. Pediatr Neonatol 2011; 52:110-2.
23. Adler SP, Chandrika T, Berman WF. Clostridium difficile associated with pseudomembranous colitis. Occurrence in a 12-week-old infant without prior antibiotic therapy. Am J Dis Child 1981; 135:820-2.
24. Singer DB, Cashore WJ, Widness JA, Campognone P, Hillemeier C. Pseudomembranous colitis in a preterm neonate. J Pediatr Gastroenterol Nutr 1986; 5:318-20.
25. El Feghaly RE, Stauber JL, Tarr PI, Haslam DB. Viral co-infections are common and are associated with higher bacterial burden in children with Clostridium difficile infection. J Pediatr Gastroenterol Nutr 2013; 57:813-6.
26. UK Department of Health. Updated guidance on the diagnosis and reporting of Clostridium difficile. Available at: https://www.gov.uk/ government/uploads/system/uploads/attachment-data/file/146808/ dh-133016.pdf.pdf. Accessed 22 April 2014.
27. Sinha I, Gallagher R, Williamson P, Smyth R. Determining the clinical relevance of outcomes for evaluation regular therapies for children with asthma-a survey of clinicians, parents and young people. Arch Dis Child 2010; 95(suppl 1):A59.
28. Sinha IP, Smyth RL, Williamson PR. Using the Delphi technique to determine which outcomes to measure in clinical trials: recommendations for the future based on a systematic review of existing studies. PLoS Med 2011; 8:e1000393.
29. Hickey HR, Jones AP, LenneyW, Williamson PR, Smyth RL. Feasibility study to inform the design of a randomised controlled trial to eradicate Pseudomonas aeruginosa infection in individuals with cystic fibrosis. Trials 2010; 11:11.
30. Wilcox MH. Overcoming barriers to effective recognition and diagnosis of Clostridium difficile infection. Clin Microbiol Infect 2012; 18(suppl 6):13-20.
31. Dethlefsen L, Huse S, Sogin ML, Relman DA. The pervasive effects of an antibiotic on the human gut microbiota, as revealed by deep 16S rRNA sequencing. PLoS Biol 2008; 6:e280.
32. Dethlefsen L, Relman DA. Incomplete recovery and individualized responses of the human distal gut microbiota to repeated antibiotic perturbation. Proc Natl Acad Sci U S A 2011; 108(suppl 1): 4554-61.